PF-06372865 In Subjects With Chronic Low Back Pain
CompletedPhase 2NCT02262754
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
PF-06372865 In Subjects With Chronic Low Back Pain
Study details
- Official title
- A Randomized, Double Blind, Placebo- And Active-controlled, 4 Week, Multi-center, Parallel Group Study Assessing The Analgesic Effect, Safety And Tolerability Of Pf-06372865 In Subjects With Chronic Low Back Pain Using Naproxen As Positive Control
- Conditions
- Interventions
- Drug: PF-06372865
- Drug: Placebo
- Drug: Naproxen
- Sponsor
- Pfizer
- Start date
- 2014-10
- Primary completion
- 2015-08
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 46
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: \- Exclusion Criteria: \-
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02262754